High Mark Wealth Management LLC Neuronetics, Inc. Transaction History

High Mark Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$2.84 - $4.52 $11,360 - $18,080	-4,000 Reduced 44.44%	5,000 $15,000
Q4 2021 Jan 20, 2022	SELL	$3.87 - $6.59 $37,016 - $63,033	-9,565 Reduced 51.52%	9,000 $40,000
Q3 2021 Nov 01, 2021	BUY	$6.22 - $15.54 $77,917 - $194,669	12,527 Added 207.47%	18,565 $122,000
Q2 2021 Aug 02, 2021	BUY	$10.15 - $17.25 $58,220 - $98,946	5,736 Added 1899.34%	6,038 $97,000
Q1 2021 Apr 22, 2021	BUY	$10.6 - $21.27 $3,201 - $6,423	302 New	302 $4,000

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $82.1M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on High Mark Wealth Management LLC with notifications on news.